Dian-tao Ni

975 total citations · 1 hit paper
10 papers, 704 citations indexed

About

Dian-tao Ni is a scholar working on Pulmonary and Respiratory Medicine, Emergency Medical Services and Molecular Biology. According to data from OpenAlex, Dian-tao Ni has authored 10 papers receiving a total of 704 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 5 papers in Emergency Medical Services and 2 papers in Molecular Biology. Recurrent topics in Dian-tao Ni's work include Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers), Pediatric health and respiratory diseases (5 papers) and School Health and Nursing Education (1 paper). Dian-tao Ni is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers), Pediatric health and respiratory diseases (5 papers) and School Health and Nursing Education (1 paper). Dian-tao Ni collaborates with scholars based in China and United States. Dian-tao Ni's co-authors include Nanshan Zhong, Pixin Ran, Changzheng Wang, Wan-zhen Yao, Dali Wang, Yumin Zhou, Bao-yuan Chen, Jiachun Lü, Chen Wang and Shengming Liu and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Respirology and Tissue and Cell.

In The Last Decade

Dian-tao Ni

10 papers receiving 695 citations

Hit Papers

Prevalence of Chronic Obstructive Pulmonary Disease in China 2007 2026 2013 2019 2007 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dian-tao Ni China 8 568 193 119 100 61 10 704
N. Anthonisen United States 5 634 1.1× 220 1.1× 229 1.9× 67 0.7× 72 1.2× 7 845
Donald Sin Canada 8 548 1.0× 233 1.2× 118 1.0× 39 0.4× 45 0.7× 17 676
Daniel Obaseki Nigeria 12 331 0.6× 147 0.8× 91 0.8× 63 0.6× 77 1.3× 33 529
Ali Kocabaş Türkiye 14 569 1.0× 283 1.5× 89 0.7× 54 0.5× 76 1.2× 32 819
Dolores Moreno Venezuela 14 521 0.9× 280 1.5× 45 0.4× 69 0.7× 61 1.0× 32 663
Sapna Madas India 11 253 0.4× 137 0.7× 86 0.7× 33 0.3× 28 0.5× 44 444
Jaymini Patel United Kingdom 13 394 0.7× 132 0.7× 89 0.7× 22 0.2× 52 0.9× 23 599
Anamika Jithoo United Kingdom 7 373 0.7× 151 0.8× 63 0.5× 33 0.3× 80 1.3× 10 493
Margit Pelkonen Finland 9 374 0.7× 231 1.2× 44 0.4× 54 0.5× 35 0.6× 12 484
Theodoric Wong United Kingdom 13 126 0.2× 78 0.4× 179 1.5× 63 0.6× 33 0.5× 28 648

Countries citing papers authored by Dian-tao Ni

Since Specialization
Citations

This map shows the geographic impact of Dian-tao Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dian-tao Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dian-tao Ni more than expected).

Fields of papers citing papers by Dian-tao Ni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dian-tao Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dian-tao Ni. The network helps show where Dian-tao Ni may publish in the future.

Co-authorship network of co-authors of Dian-tao Ni

This figure shows the co-authorship network connecting the top 25 collaborators of Dian-tao Ni. A scholar is included among the top collaborators of Dian-tao Ni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dian-tao Ni. Dian-tao Ni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Pan, Xing Q., et al.. (2019). KIF18B as a regulator in microtubule movement accelerates tumor progression and triggers poor outcome in lung adenocarcinoma. Tissue and Cell. 61. 44–50. 18 indexed citations
2.
Zhou, Yumin, Chen Wang, Wan-zhen Yao, et al.. (2013). [The prevalence and risk factors of bronchiectasis in residents aged 40 years old and above in seven cities in China].. PubMed. 52(5). 379–82. 32 indexed citations
3.
Yao, Wan-zhen, Nanshan Zhong, Yumin Zhou, et al.. (2010). Asymptomatic patients of chronic obstructive pulmonary disease in China.. PubMed. 123(12). 1494–9. 22 indexed citations
4.
Lu, Ming, Wan-zhen Yao, Nanshan Zhong, et al.. (2010). Chronic obstructive pulmonary disease in the absence of chronic bronchitis in China. Respirology. 15(7). 1072–1078. 23 indexed citations
5.
Zhou, Yumin, Chen Wang, Wan-zhen Yao, et al.. (2009). [Current status of prevention and management of chronic obstructive pulmonary disease in rural area in China].. PubMed. 48(5). 358–61. 12 indexed citations
6.
Zhou, Yumin, Chen Wang, Wan-zhen Yao, et al.. (2009). [The quality of life of patients with chronic obstructive pulmonary disease and correlated factors].. PubMed. 32(4). 248–52. 5 indexed citations
7.
Zhong, Nanshan, Chen Wang, Wan-zhen Yao, et al.. (2007). Prevalence of Chronic Obstructive Pulmonary Disease in China. American Journal of Respiratory and Critical Care Medicine. 176(8). 753–760. 558 indexed citations breakdown →
8.
Ran, Pixin, Chen Wang, Wan-zhen Yao, et al.. (2007). [A study on the correlation of body mass index with chronic obstructive pulmonary disease and quality of life].. PubMed. 30(1). 18–22. 17 indexed citations
9.
Ran, Pixin, Chen Wang, Wan-zhen Yao, et al.. (2006). [The risk factors for chronic obstructive pulmonary disease in females in Chinese rural areas].. PubMed. 45(12). 974–9. 16 indexed citations
10.
Ni, Dian-tao, et al.. (2003). [Cost analysis of Shenqi Fuzheng injection on reducing adverse effects during chemotherapy].. PubMed. 24(2). 130–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026